13F Filings History of RA CAPITAL MANAGEMENT, L.P.

Latest 13F report
Q4 2025 - 17 Feb 2026
Value $
$9,718,412,784
Signature - Title
Rajeev Shah - Authorized Signatory
Location
Boston, MA
Summary
This page shows a list of all the recent 13F filings made by RA CAPITAL MANAGEMENT, L.P.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. RA CAPITAL MANAGEMENT, L.P. reported 72 stock holdings with total value $9,718,412,784 as of Q4 2025. Top holdings included ASND, CDTX, RYTM, RNA, and PCVX.

Notify me when RA CAPITAL MANAGEMENT, L.P. files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 72 $9,718,412,784 +$1,016,633,901 -$1,043,462,038 -$26,828,137 ASND, CDTX, RYTM, RNA, PCVX 13F-HR 17 Feb 2026, 16:30
Q3 2025 67 $8,115,527,458 +$600,328,003 -$311,021,056 +$289,306,947 ASND, RYTM, PCVX, RNA, CDTX 13F-HR 14 Nov 2025, 16:04
Q2 2025 63 $5,935,681,007 +$266,499,608 -$554,796,617 -$288,297,009 ASND, PCVX, RYTM, JANX, RNA 13F-HR 14 Aug 2025, 16:35
Q1 2025 85 $5,987,912,728 +$730,613,502 -$788,292,259 -$57,678,757 ASND, PCVX, RYTM, JANX, NAMS 13F-HR 15 May 2025, 16:44
Q4 2024 89 $7,514,204,405 +$813,355,430 -$736,480,848 +$76,874,582 ASND, PCVX, JANX, RYTM, LEGN 13F-HR 14 Feb 2025, 16:29
Q3 2024 81 $8,673,579,253 +$675,689,567 -$462,520,644 +$213,168,923 ASND, PCVX, JANX, LEGN, RYTM 13F-HR 14 Nov 2024, 16:33
Q2 2024 78 $7,560,766,669 +$886,487,861 -$291,190,105 +$595,297,756 ASND, PCVX, JANX, LEGN, RYTM 13F-HR 14 Aug 2024, 16:13
Q1 2024 1 $61,347,309 $0 $0 $0 CGON New Holdings 17 May 2024, 16:30
Q1 2024 76 $7,860,142,471 +$1,488,344,733 -$1,208,514,935 +$279,829,798 ASND, PCVX, LEGN, JANX, AVTE 13F-HR 15 May 2024, 17:20
Q4 2023 62 $6,402,499,260 +$489,681,314 -$418,728,912 +$70,952,402 ASND, IMGN, PCVX, LEGN, RYTM 13F-HR 14 Feb 2024, 17:01
Q3 2023 1 $37,587,910 $0 $0 $0 CTKB New Holdings 15 Nov 2023, 08:08
Q3 2023 66 $5,079,719,232 +$736,052,803 -$472,607,961 +$263,444,842 ASND, LEGN, PCVX, IMGN, ETNB 13F-HR 14 Nov 2023, 17:00
Q2 2023 54 $5,296,462,962 +$899,288,631 -$620,466,955 +$278,821,676 ASND, LEGN, PCVX, DICE, ETNB 13F-HR 14 Aug 2023, 16:30
Q1 2023 59 $4,417,403,494 +$475,231,494 -$255,800,681 +$219,430,813 ASND, PCVX, DICE, ETNB, AVTE 13F-HR 15 May 2023, 16:15
Q4 2022 70 $4,930,699,654 +$643,945,136 -$823,089,100 -$179,143,964 ASND, PCVX, AVTE, DICE, VRNA 13F-HR 14 Feb 2023, 16:48
Q3 2022 81 $4,678,509,000 +$526,463,070 -$316,099,157 +$210,363,913 ASND, BIIB, CTKB, FMTX, DAWN 13F-HR 14 Nov 2022, 16:39
Q2 2022 88 $3,750,535,000 +$395,840,512 -$453,131,439 -$57,290,927 ASND, BIIB, CTKB, AVTE, DAWN 13F-HR 15 Aug 2022, 17:22
Q1 2022 96 $4,583,149,000 +$693,791,177 -$426,250,620 +$267,540,557 ASND, BIIB, AVTE, CTKB, ITOS 13F-HR 16 May 2022, 16:34
Q4 2021 97 $5,671,942,000 +$469,329,832 -$314,221,483 +$155,108,349 ASND, NVAX, ITOS, TVTX, JANX 13F-HR 14 Feb 2022, 16:13
Q3 2021 95 $7,216,744,000 +$1,848,265,216 -$667,801,732 +$1,180,463,484 ASND, NVAX, ELYM, IVVD, FMTX 13F-HR 15 Nov 2021, 16:36
Q2 2021 92 $6,157,473,000 +$1,279,152,347 -$515,140,659 +$764,011,688 ASND, NVAX, FMTX, JANX, VOR 13F-HR 16 Aug 2021, 16:35
Q1 2021 82 $6,562,653,000 +$1,293,217,344 -$1,375,798,134 -$82,580,790 ASND, NVAX, VOR, AVIR, FMTX 13F-HR 17 May 2021, 16:31
Q4 2020 82 $7,112,440,000 +$1,629,129,407 -$749,304,907 +$879,824,500 ASND, TGTX, NVAX, NKTX, FMTX 13F-HR 16 Feb 2021, 16:32
Q3 2020 70 $5,467,231,000 +$1,163,450,869 -$705,005,548 +$458,445,321 ASND, FMTX, CCXI, PCVX, TGTX 13F-HR 16 Nov 2020, 16:34
Q2 2020 57 $5,086,141,000 +$1,685,688,646 -$539,212,078 +$1,146,476,568 ASND, FMTX, NVAX, CCXI, TGTX 13F-HR 14 Aug 2020, 16:23
Q1 2020 48 $3,108,681,000 +$995,211,227 -$827,743,944 +$167,467,283 ASND, RARX, CCXI, ARVN, ZGNX 13F-HR 15 May 2020, 16:30
Q4 2019 34 $3,297,714,000 +$774,273,237 -$142,511,524 +$631,761,713 THOR, ASND, RARX, ARVN, CCXI 13F-HR 14 Feb 2020, 16:37
Q3 2019 32 $1,678,386,000 +$211,927,550 -$122,730,314 +$89,197,236 ASND, WVE, THOR, RARX, ZGNX 13F-HR 14 Nov 2019, 16:32
Q2 2019 25 $1,728,811,000 +$185,299,568 -$477,263,591 -$291,964,023 ASND, WVE, ZGNX, RARX, THOR 13F-HR 14 Aug 2019, 16:30
Q1 2019 29 $2,227,955,000 +$224,764,597 -$96,761,939 +$128,002,658 ASND, WVE, THOR, ZGNX, RARX 13F-HR 15 May 2019, 16:31
Q4 2018 25 $1,624,816,000 +$373,562,823 -$215,455,233 +$158,107,590 WVE, ASND, THOR, ZGNX, BCRX 13F-HR 14 Feb 2019, 16:59
Q3 2018 26 $1,870,521,000 +$234,320,139 -$96,754,119 +$137,566,020 WVE, ASND, SLDB, ECYT, ZGNX 13F-HR 14 Nov 2018, 16:30
Q2 2018 27 $1,540,247,000 +$306,989,755 -$171,226,369 +$135,763,386 WVE, ASND, SLDB, ECYT, MNTA 13F-HR 14 Aug 2018, 16:35
Q1 2018 31 $1,305,208,000 +$127,581,716 -$267,280,522 -$139,698,806 WVE, ASND, AVXS, MYOV, SAGE 13F-HR 15 May 2018, 16:15
Q4 2017 27 $1,195,149,000 +$286,499,971 -$220,999,764 +$65,500,207 WVE, ASND, AVXS, SAGE, IFRX 13F-HR 14 Feb 2018, 16:55
Q3 2017 27 $1,057,119,000 +$170,277,528 -$128,723,326 +$41,554,202 ASND, WVE, AVXS, BHVN, ACHN 13F-HR 14 Nov 2017, 16:34
Q2 2017 22 $871,430,000 +$233,993,486 -$125,553,822 +$108,439,664 ASND, WVE, AVXS, ACHN, BHVN 13F-HR 14 Aug 2017, 16:39
Q1 2017 24 $815,257,000 +$79,100,263 -$76,914,609 +$2,185,654 WVE, ASND, AVXS, ACHN, AQXP 13F-HR 15 May 2017, 16:36
Q4 2016 1 $18,660,000 $0 $0 $0 MYOV New Holdings 16 Feb 2017, 16:04
Q4 2016 27 $705,844,000 +$106,287,097 -$278,854,055 -$172,566,958 WVE, ASND, AVXS, ACHN, AQXP Restatement 16 Feb 2017, 16:03
Q3 2016 31 $965,936,000 +$117,901,408 -$75,449,353 +$42,452,055 WVE, ACHN, ASND, AVXS, AXGT 13F-HR 14 Nov 2016, 17:12
Q2 2016 32 $722,235,000 +$21,797,695 -$119,941,962 -$98,144,267 WVE, ACHN, AXGT, AVXS, ACRS 13F-HR 15 Aug 2016, 16:31
Q1 2016 42 $782,348,000 +$194,305,740 -$157,579,976 +$36,725,764 WVE, ACHN, AXGT, ACRS, NKTR 13F-HR 16 May 2016, 16:36
Q4 2015 37 $1,010,538,000 +$290,489,011 -$128,845,755 +$161,643,256 ACHN, WVE, DYAX, AXGT, ACRS 13F-HR 16 Feb 2016, 16:39
Q3 2015 47 $696,301,000 +$186,041,437 -$209,342,620 -$23,301,183 ACHN, AXGT, DYAX, COLL, TGTX 13F-HR 13 Nov 2015, 16:10
Q2 2015 58 $927,565,000 +$313,751,642 -$351,323,128 -$37,571,486 AXGT, ACHN, DYAX, TGTX, RGLS 13F-HR 13 Aug 2015, 16:23
Q1 2015 56 $912,869,000 +$224,275,180 -$160,252,218 +$64,022,962 ACHN, DYAX, BCRX, RGLS, DRNA Restatement 06 Jul 2015, 14:53
Q4 2014 48 $767,165,000 +$217,953,449 -$230,217,337 -$12,263,888 BCRX, ACHN, RGLS, DYAX, TGTX 13F-HR 17 Feb 2015, 16:14
Q3 2014 43 $621,635,000 +$213,214,799 -$310,204,661 -$96,989,862 DYAX, BCRX, ACHN, AVNR, SNSS 13F-HR 14 Nov 2014, 16:23
Q2 2014 24 $706,005,000 +$54,091,483 -$398,164,065 -$344,072,582 ACHN, DYAX, ENTA, DRNA, SGMO 13F-HR 14 Aug 2014, 16:11
Q1 2014 29 $973,492,000 +$280,715,131 -$60,543,393 +$220,171,738 SGMO, ACHN, DRNA, DYAX, TXMD 13F-HR 15 May 2014, 13:38
Q4 2013 24 $647,800,000 $0 $0 $0 ACHN, SGMO, TXMD, NVAX, OPHT 13F-HR 14 Feb 2014, 11:49